Therapeutics
Tau
- Study completed / Planned end date
- Planned end date unavailable
- Study aborted
| Tau | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AADvac1 |
Phase 1, Phase 2
|
||||||||||||||
| BIIB080 |
Phase 1/2
|
||||||||||||||
| Gosuranemab |
Phase 2
|
||||||||||||||
| HMTM |
Phase 2, Phase 2/3, Phase 3
|
||||||||||||||
| Tilavonemab |
Phase 2
|
||||||||||||||
| Zagotenemab |
Phase 2
|